A Phase II Study of Cetuximab and MFOLFOX6 in MCRC Including Prospective Early Tumor Shrinkage Analysis (JACCRO-CC05)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2013-06, Vol.24, p.iv94-iv94
Hauptverfasser: Tsuji, Akihito, Nakamura, Masato, Sunakawa, Yu, Kochi, Mitsugu, Denda, Tadamichi, Yamaguchi, Tatsuro, Shimada, Ken, Tani, Satoshi, Takagane, Akinori, Kotaka, Masahito, Nakayama, Izuma, Yonemura, Yutaka, Kuramochi, Hidekazu, Koike, Junichi, Takeuchi, Masahiro, Ichikawa, Wataru, Fujii, Masashi, Nakajima, Toshifusa
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page iv94
container_issue
container_start_page iv94
container_title Annals of oncology
container_volume 24
creator Tsuji, Akihito
Nakamura, Masato
Sunakawa, Yu
Kochi, Mitsugu
Denda, Tadamichi
Yamaguchi, Tatsuro
Shimada, Ken
Tani, Satoshi
Takagane, Akinori
Kotaka, Masahito
Nakayama, Izuma
Yonemura, Yutaka
Kuramochi, Hidekazu
Koike, Junichi
Takeuchi, Masahiro
Ichikawa, Wataru
Fujii, Masashi
Nakajima, Toshifusa
description
doi_str_mv 10.1093/annonc/mdt203.206
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdt203_206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S092375341954697X</els_id><sourcerecordid>S092375341954697X</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2516-68e969f647150ac35f3dbf798720b94e7bf6dd0e0f34a65242164e041fcf91c83</originalsourceid><addsrcrecordid>eNp9kE9PwjAYhxujiYh-AG896mHQdltH42lpRDGQEcDE29L1D1ShIy0j7ts7M8-e3tPz5vc8ANxjNMKIxWPhXO3k-KBOBMUjgugFGOCUsmiCEnwJBoiROMrSOLkGNyF8IoQoI2wAmhwudyJoOJvB9alRLawN5PrUfNuDqKBwCi6mxXxafFBoHVzwFYczJ_eNsm4Ll74ORy1P9qzhs_D7Fm6aQ-3heuet-xJbDXMn9m2wAT685ZyviohzlD7egisj9kHf_d0heJ8-b_hrNC9eZjyfR5KkmEZ0ohllhiYZTpGQcWpiVZmMTTKCKpborDJUKaSRiRNBU5IQTBPdCRtpGJaTeAhw_1d2Q4PXpjz6zsu3JUblb7ey71b23cquW8c89Yzuhp2t9mWQVjuplfWdaqlq-w_9A2xadaU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Phase II Study of Cetuximab and MFOLFOX6 in MCRC Including Prospective Early Tumor Shrinkage Analysis (JACCRO-CC05)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Tsuji, Akihito ; Nakamura, Masato ; Sunakawa, Yu ; Kochi, Mitsugu ; Denda, Tadamichi ; Yamaguchi, Tatsuro ; Shimada, Ken ; Tani, Satoshi ; Takagane, Akinori ; Kotaka, Masahito ; Nakayama, Izuma ; Yonemura, Yutaka ; Kuramochi, Hidekazu ; Koike, Junichi ; Takeuchi, Masahiro ; Ichikawa, Wataru ; Fujii, Masashi ; Nakajima, Toshifusa</creator><creatorcontrib>Tsuji, Akihito ; Nakamura, Masato ; Sunakawa, Yu ; Kochi, Mitsugu ; Denda, Tadamichi ; Yamaguchi, Tatsuro ; Shimada, Ken ; Tani, Satoshi ; Takagane, Akinori ; Kotaka, Masahito ; Nakayama, Izuma ; Yonemura, Yutaka ; Kuramochi, Hidekazu ; Koike, Junichi ; Takeuchi, Masahiro ; Ichikawa, Wataru ; Fujii, Masashi ; Nakajima, Toshifusa</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdt203.206</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2013-06, Vol.24, p.iv94-iv94</ispartof><rights>2013 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2516-68e969f647150ac35f3dbf798720b94e7bf6dd0e0f34a65242164e041fcf91c83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Tsuji, Akihito</creatorcontrib><creatorcontrib>Nakamura, Masato</creatorcontrib><creatorcontrib>Sunakawa, Yu</creatorcontrib><creatorcontrib>Kochi, Mitsugu</creatorcontrib><creatorcontrib>Denda, Tadamichi</creatorcontrib><creatorcontrib>Yamaguchi, Tatsuro</creatorcontrib><creatorcontrib>Shimada, Ken</creatorcontrib><creatorcontrib>Tani, Satoshi</creatorcontrib><creatorcontrib>Takagane, Akinori</creatorcontrib><creatorcontrib>Kotaka, Masahito</creatorcontrib><creatorcontrib>Nakayama, Izuma</creatorcontrib><creatorcontrib>Yonemura, Yutaka</creatorcontrib><creatorcontrib>Kuramochi, Hidekazu</creatorcontrib><creatorcontrib>Koike, Junichi</creatorcontrib><creatorcontrib>Takeuchi, Masahiro</creatorcontrib><creatorcontrib>Ichikawa, Wataru</creatorcontrib><creatorcontrib>Fujii, Masashi</creatorcontrib><creatorcontrib>Nakajima, Toshifusa</creatorcontrib><title>A Phase II Study of Cetuximab and MFOLFOX6 in MCRC Including Prospective Early Tumor Shrinkage Analysis (JACCRO-CC05)</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kE9PwjAYhxujiYh-AG896mHQdltH42lpRDGQEcDE29L1D1ShIy0j7ts7M8-e3tPz5vc8ANxjNMKIxWPhXO3k-KBOBMUjgugFGOCUsmiCEnwJBoiROMrSOLkGNyF8IoQoI2wAmhwudyJoOJvB9alRLawN5PrUfNuDqKBwCi6mxXxafFBoHVzwFYczJ_eNsm4Ll74ORy1P9qzhs_D7Fm6aQ-3heuet-xJbDXMn9m2wAT685ZyviohzlD7egisj9kHf_d0heJ8-b_hrNC9eZjyfR5KkmEZ0ohllhiYZTpGQcWpiVZmMTTKCKpborDJUKaSRiRNBU5IQTBPdCRtpGJaTeAhw_1d2Q4PXpjz6zsu3JUblb7ey71b23cquW8c89Yzuhp2t9mWQVjuplfWdaqlq-w_9A2xadaU</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Tsuji, Akihito</creator><creator>Nakamura, Masato</creator><creator>Sunakawa, Yu</creator><creator>Kochi, Mitsugu</creator><creator>Denda, Tadamichi</creator><creator>Yamaguchi, Tatsuro</creator><creator>Shimada, Ken</creator><creator>Tani, Satoshi</creator><creator>Takagane, Akinori</creator><creator>Kotaka, Masahito</creator><creator>Nakayama, Izuma</creator><creator>Yonemura, Yutaka</creator><creator>Kuramochi, Hidekazu</creator><creator>Koike, Junichi</creator><creator>Takeuchi, Masahiro</creator><creator>Ichikawa, Wataru</creator><creator>Fujii, Masashi</creator><creator>Nakajima, Toshifusa</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201306</creationdate><title>A Phase II Study of Cetuximab and MFOLFOX6 in MCRC Including Prospective Early Tumor Shrinkage Analysis (JACCRO-CC05)</title><author>Tsuji, Akihito ; Nakamura, Masato ; Sunakawa, Yu ; Kochi, Mitsugu ; Denda, Tadamichi ; Yamaguchi, Tatsuro ; Shimada, Ken ; Tani, Satoshi ; Takagane, Akinori ; Kotaka, Masahito ; Nakayama, Izuma ; Yonemura, Yutaka ; Kuramochi, Hidekazu ; Koike, Junichi ; Takeuchi, Masahiro ; Ichikawa, Wataru ; Fujii, Masashi ; Nakajima, Toshifusa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2516-68e969f647150ac35f3dbf798720b94e7bf6dd0e0f34a65242164e041fcf91c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsuji, Akihito</creatorcontrib><creatorcontrib>Nakamura, Masato</creatorcontrib><creatorcontrib>Sunakawa, Yu</creatorcontrib><creatorcontrib>Kochi, Mitsugu</creatorcontrib><creatorcontrib>Denda, Tadamichi</creatorcontrib><creatorcontrib>Yamaguchi, Tatsuro</creatorcontrib><creatorcontrib>Shimada, Ken</creatorcontrib><creatorcontrib>Tani, Satoshi</creatorcontrib><creatorcontrib>Takagane, Akinori</creatorcontrib><creatorcontrib>Kotaka, Masahito</creatorcontrib><creatorcontrib>Nakayama, Izuma</creatorcontrib><creatorcontrib>Yonemura, Yutaka</creatorcontrib><creatorcontrib>Kuramochi, Hidekazu</creatorcontrib><creatorcontrib>Koike, Junichi</creatorcontrib><creatorcontrib>Takeuchi, Masahiro</creatorcontrib><creatorcontrib>Ichikawa, Wataru</creatorcontrib><creatorcontrib>Fujii, Masashi</creatorcontrib><creatorcontrib>Nakajima, Toshifusa</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsuji, Akihito</au><au>Nakamura, Masato</au><au>Sunakawa, Yu</au><au>Kochi, Mitsugu</au><au>Denda, Tadamichi</au><au>Yamaguchi, Tatsuro</au><au>Shimada, Ken</au><au>Tani, Satoshi</au><au>Takagane, Akinori</au><au>Kotaka, Masahito</au><au>Nakayama, Izuma</au><au>Yonemura, Yutaka</au><au>Kuramochi, Hidekazu</au><au>Koike, Junichi</au><au>Takeuchi, Masahiro</au><au>Ichikawa, Wataru</au><au>Fujii, Masashi</au><au>Nakajima, Toshifusa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Phase II Study of Cetuximab and MFOLFOX6 in MCRC Including Prospective Early Tumor Shrinkage Analysis (JACCRO-CC05)</atitle><jtitle>Annals of oncology</jtitle><date>2013-06</date><risdate>2013</risdate><volume>24</volume><spage>iv94</spage><epage>iv94</epage><pages>iv94-iv94</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdt203.206</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2013-06, Vol.24, p.iv94-iv94
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdt203_206
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title A Phase II Study of Cetuximab and MFOLFOX6 in MCRC Including Prospective Early Tumor Shrinkage Analysis (JACCRO-CC05)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T02%3A02%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Phase%20II%20Study%20of%20Cetuximab%20and%20MFOLFOX6%20in%20MCRC%20Including%20Prospective%20Early%20Tumor%20Shrinkage%20Analysis%20(JACCRO-CC05)&rft.jtitle=Annals%20of%20oncology&rft.au=Tsuji,%20Akihito&rft.date=2013-06&rft.volume=24&rft.spage=iv94&rft.epage=iv94&rft.pages=iv94-iv94&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdt203.206&rft_dat=%3Celsevier_cross%3ES092375341954697X%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S092375341954697X&rfr_iscdi=true